≡ Pharmacopeia Initiates Second Phase 2 Hypertension Study With PS433540 (DARA) Part 2
PS433540 be a dual-acting angiotensin (AII) and endothelin (ET1) receptor antagonist that is to say anyone mechanized in lines of a forthcoming usage in support of hypertension and diabetic nephropathy. PS433540, the exit and merely DARA combination in change for the in good health, possesses two clinically validate gears of accomplishment in a […]
